cell-based meat
-
DATABASE (857)
-
ARTICLES (608)
UBS is a Switzerland-based financial institution providing banking, wealth management, and securities services. Originally established in 1862 as the Bank in Winterthur, it is the largest Swiss banking institution. UBS engages in venture capital activities as part of its investment banking services. In 2020, UBS began a partnership with venture capital firm Anthemis to launch UBS Next, a $200m fund that will invest in fintech and other tech startups.
UBS is a Switzerland-based financial institution providing banking, wealth management, and securities services. Originally established in 1862 as the Bank in Winterthur, it is the largest Swiss banking institution. UBS engages in venture capital activities as part of its investment banking services. In 2020, UBS began a partnership with venture capital firm Anthemis to launch UBS Next, a $200m fund that will invest in fintech and other tech startups.
Based in New York City, Lerer Hippeau mainly invests in seed and early-stage startups based in the US. Founded in 2010 by managing partners Kenneth Lerer, Ben Lerer and Eric Hippeau, the VC operates several funds offering initial investments of $1m per startup. Kenneth Lerer is the co-founder of Huffington Post and longtime chairman of BuzzFeed. Hippeau was the CEO of Huffington Post and ex-managing partner of Softbank Capital that invested in Huffington Post.Its 400+ startups also get support for business growth by tapping into tech ecosystems like New York, San Francisco and Los Angeles. Its 80+ exits include Giphy (GIF) that was acquired by Facebook and home-fitness studio Mirror acquired by Lululemon. However, the IPO by portfolio company Bed-in-a-box online retailer Casper was below market expectations. The loss-making e-commerce unicorn went public at $12 a share in February 2020, closing at $13.50 on its first day out, for a market capitalization of less than half the $1.1 billion Casper was valued at in a private funding round in 2019.
Based in New York City, Lerer Hippeau mainly invests in seed and early-stage startups based in the US. Founded in 2010 by managing partners Kenneth Lerer, Ben Lerer and Eric Hippeau, the VC operates several funds offering initial investments of $1m per startup. Kenneth Lerer is the co-founder of Huffington Post and longtime chairman of BuzzFeed. Hippeau was the CEO of Huffington Post and ex-managing partner of Softbank Capital that invested in Huffington Post.Its 400+ startups also get support for business growth by tapping into tech ecosystems like New York, San Francisco and Los Angeles. Its 80+ exits include Giphy (GIF) that was acquired by Facebook and home-fitness studio Mirror acquired by Lululemon. However, the IPO by portfolio company Bed-in-a-box online retailer Casper was below market expectations. The loss-making e-commerce unicorn went public at $12 a share in February 2020, closing at $13.50 on its first day out, for a market capitalization of less than half the $1.1 billion Casper was valued at in a private funding round in 2019.
Founded and headed by Susan Choe in 2018, Katalyst Ventures is based in San Francisco with a debut fund of $34m raised in 2018. Choe is also a partner at another Zipline investor Visionnaire Ventures (VV) also based in Silicon Valley. Katalyst invests in seed and early-stage tech startups with human-centric solutions. About 45% of the VC funds are invested in startups with women as CEO or CTO. By February 2020, the Kalatyst portfolio included 22 enterprises and three exits.The founder of Outspark was removed as CEO by the board of directors due to disagreements over the sale of Outspark. She had used her own money in 2006 to create Outspark, a data-driven publishing platform for game developers. Outspark was eventually sold to Axel Springer and Choe went left the company to join Taizo Son’s venture capital group. In 2013, VV was set up to support tech startups in the US. Choe had worked for Yahoo! and also was the COO of the public-listed holding company of South Korean search and media company NHN.
Founded and headed by Susan Choe in 2018, Katalyst Ventures is based in San Francisco with a debut fund of $34m raised in 2018. Choe is also a partner at another Zipline investor Visionnaire Ventures (VV) also based in Silicon Valley. Katalyst invests in seed and early-stage tech startups with human-centric solutions. About 45% of the VC funds are invested in startups with women as CEO or CTO. By February 2020, the Kalatyst portfolio included 22 enterprises and three exits.The founder of Outspark was removed as CEO by the board of directors due to disagreements over the sale of Outspark. She had used her own money in 2006 to create Outspark, a data-driven publishing platform for game developers. Outspark was eventually sold to Axel Springer and Choe went left the company to join Taizo Son’s venture capital group. In 2013, VV was set up to support tech startups in the US. Choe had worked for Yahoo! and also was the COO of the public-listed holding company of South Korean search and media company NHN.
COO and co-founder of iLoF
Mehak Mumtaz grew up in Pakistan and decided to study biochemistry when she saw her brother suffering from an unknown learning disability. Her parents, both medical doctors, could not get an accurate diagnosis for their son. In her search to understand the molecular mechanisms behind diseases, she applied to study at the University of Oxford. In 2008, she was granted the Reach Oxford Scholarship and graduated with a master’s in biochemistry in 2012. In 2015, the St Hilda’s alumna worked as an undergraduate tutor at Oxford while completing a PhD in pathology, specializing in oncology and cancer biology.In 2018, she worked on a rare cancer project as EIT Health Business Innovation fellow for a year. She left academia and joined a three-month bioentrepreneur bootcamp in Munich and a one-month Lev8 Woman Program at her alma mater’s Oxford Foundry. She joined EY-Parthenon in London as a strategy consultant in April 2019.In 2019, Mumtaz also met the iLoF co-founding team at the EIT Health Wild Card venture-building program. iLoF is a medtech startup that focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.She joined iLoF as COO and co-founder in December 2019 and left her full-time consultancy role at EY in March 2020.
Mehak Mumtaz grew up in Pakistan and decided to study biochemistry when she saw her brother suffering from an unknown learning disability. Her parents, both medical doctors, could not get an accurate diagnosis for their son. In her search to understand the molecular mechanisms behind diseases, she applied to study at the University of Oxford. In 2008, she was granted the Reach Oxford Scholarship and graduated with a master’s in biochemistry in 2012. In 2015, the St Hilda’s alumna worked as an undergraduate tutor at Oxford while completing a PhD in pathology, specializing in oncology and cancer biology.In 2018, she worked on a rare cancer project as EIT Health Business Innovation fellow for a year. She left academia and joined a three-month bioentrepreneur bootcamp in Munich and a one-month Lev8 Woman Program at her alma mater’s Oxford Foundry. She joined EY-Parthenon in London as a strategy consultant in April 2019.In 2019, Mumtaz also met the iLoF co-founding team at the EIT Health Wild Card venture-building program. iLoF is a medtech startup that focuses on personalized medicine through the use of AI and photonics to create optical fingerprints in a cloud-based library to gather and manages disease biomarkers and biological profiles.She joined iLoF as COO and co-founder in December 2019 and left her full-time consultancy role at EY in March 2020.
Chairman of the Board, co-founder, co-inventor of NovoNutrients
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Media Digital Ventures is the first Spanish Cross-Media fund focusing on Media for Equity. It holds multichannel advertising assets across major media sectors. Based in Barcelona, MDV also creates multimedia and advertising campaigns for scaling high-growth startups in return for equity.MDV is co-founded by Gerard Olivé and Miguel Vicente. Both are serial entrepreneurs, investors and co-founders of Antai Venture Builder, Wallapop, Deliberry and Chicplace. Vicente, who exited LetsBonus which he founded in 2009, is also the president of Barcelona Tech City.
Media Digital Ventures is the first Spanish Cross-Media fund focusing on Media for Equity. It holds multichannel advertising assets across major media sectors. Based in Barcelona, MDV also creates multimedia and advertising campaigns for scaling high-growth startups in return for equity.MDV is co-founded by Gerard Olivé and Miguel Vicente. Both are serial entrepreneurs, investors and co-founders of Antai Venture Builder, Wallapop, Deliberry and Chicplace. Vicente, who exited LetsBonus which he founded in 2009, is also the president of Barcelona Tech City.
Partech Ventures is a global venture capital firm established in San Francisco in 1982 as Paribas Technologies, a subsidiary of French bank Paribas that currently holds €1.3 billion in assets under its management. In addition to San Francisco, Partech also has offices in Paris, Berlin and Dakar, Senegal, with the latter focused exclusively on African startups. The company is now based in Paris and has invested in over 300 companies across different funding stages with 48 exits to date.
Partech Ventures is a global venture capital firm established in San Francisco in 1982 as Paribas Technologies, a subsidiary of French bank Paribas that currently holds €1.3 billion in assets under its management. In addition to San Francisco, Partech also has offices in Paris, Berlin and Dakar, Senegal, with the latter focused exclusively on African startups. The company is now based in Paris and has invested in over 300 companies across different funding stages with 48 exits to date.
Qingdao Haier Venture Capital is the investment arm of China-based electronics manufacturer Haier Group. The Haier SAIF fund was established in September 2014, in partnership with private equity firm SAIF Partners and other investors. The RMB 320m investment fund is managed by SAIF Partners. The fund mainly invests smart home product developers and related sectors like AI, IoT and big data. As of December 2017, it has invested in 16 startups.
Qingdao Haier Venture Capital is the investment arm of China-based electronics manufacturer Haier Group. The Haier SAIF fund was established in September 2014, in partnership with private equity firm SAIF Partners and other investors. The RMB 320m investment fund is managed by SAIF Partners. The fund mainly invests smart home product developers and related sectors like AI, IoT and big data. As of December 2017, it has invested in 16 startups.
Hong Kong-based Jeneration Capital was founded in 2015 by Jimmy Chang, a former banker at Morgan Stanley. It now manages approximately US$2bn in capital, utilizing a multi-strategy investment approach with an emphasis on direct investment and dynamic asset allocation across private equity, public equity and diversified fund investments. In terms of direct investment, Jeneration Capital mainly invests in growth-stage technology-enabled companies in the Asia-Pacific region, with a focus on Greater China.
Hong Kong-based Jeneration Capital was founded in 2015 by Jimmy Chang, a former banker at Morgan Stanley. It now manages approximately US$2bn in capital, utilizing a multi-strategy investment approach with an emphasis on direct investment and dynamic asset allocation across private equity, public equity and diversified fund investments. In terms of direct investment, Jeneration Capital mainly invests in growth-stage technology-enabled companies in the Asia-Pacific region, with a focus on Greater China.
Singapore-based VC Jungle Ventures set up its SeedPlus fund in 2016. The SGD 25m fund is backed by a diverse range of investors including Eight Roads, Infocomm Investments, Accel Partners, RNT Associates, SGInnovate and Cisco. A fund run by Jungle Ventures partner and Indian tycoon Ratan Tata has also contributed to SeedPlus.Early-stage investments of SGD 0.5–1m are available for startups in Southeast Asia. The fund also provides hands-on expertise and support services, including resources from partners like Google SEA and PwC Singapore.
Singapore-based VC Jungle Ventures set up its SeedPlus fund in 2016. The SGD 25m fund is backed by a diverse range of investors including Eight Roads, Infocomm Investments, Accel Partners, RNT Associates, SGInnovate and Cisco. A fund run by Jungle Ventures partner and Indian tycoon Ratan Tata has also contributed to SeedPlus.Early-stage investments of SGD 0.5–1m are available for startups in Southeast Asia. The fund also provides hands-on expertise and support services, including resources from partners like Google SEA and PwC Singapore.
Shanghai-based Shengyin Incubation is a wholly-owned subsidiary of Shengyin Investment, specialized in private equity investment, merger & acquisition, investment consultancy and startup incubation. It invests mainly in early-stage startups in agritech, new retail, education and enterprise services. Shengyin Incubation is also eyeing commercial opportunities brought by new technologies such as AI, blockchain and IoT. Since its establishment in 2006, Shengyin Incubation has invested in over 100 startups, of which 26 have been listed on China's stock exchanges in Shanghai and Shenzhen.
Shanghai-based Shengyin Incubation is a wholly-owned subsidiary of Shengyin Investment, specialized in private equity investment, merger & acquisition, investment consultancy and startup incubation. It invests mainly in early-stage startups in agritech, new retail, education and enterprise services. Shengyin Incubation is also eyeing commercial opportunities brought by new technologies such as AI, blockchain and IoT. Since its establishment in 2006, Shengyin Incubation has invested in over 100 startups, of which 26 have been listed on China's stock exchanges in Shanghai and Shenzhen.
Big Sur Ventures is a Spanish VC based in Madrid. It was co-founded by Jose Miguel Herrero and Manuel Matés both with extensive international experience in leading technology products and services companies and M&A. The fund invests in companies focused on SaaS, online marketplace and platforms, IT and digital media. Investments range from seed to later growth stage. The VC usually represents the first institutional capital in a company, leading or co-leading the round with capital injection of between €100,000 and €400.000 per round.
Big Sur Ventures is a Spanish VC based in Madrid. It was co-founded by Jose Miguel Herrero and Manuel Matés both with extensive international experience in leading technology products and services companies and M&A. The fund invests in companies focused on SaaS, online marketplace and platforms, IT and digital media. Investments range from seed to later growth stage. The VC usually represents the first institutional capital in a company, leading or co-leading the round with capital injection of between €100,000 and €400.000 per round.
Founded in 2006, Abacus Alpha is a German VC that has invested in water or industry service companies instead of the typical tech startups. Based in Frankenthal, Rheinland-Pfalz, it is the investment arm of German multinational, KSB Group, a pump and valve producer. Its most recent investments were the 2019 undisclosed seed funding of industrial tech company Applied Nano Services, the 2018 undisclosed seed round in desalination innovator Salinova and the 2017 undisclosed seed investment in AddVolt, pioneer of renewable energy generation technology to replace diesel engines for cold chain transport.
Founded in 2006, Abacus Alpha is a German VC that has invested in water or industry service companies instead of the typical tech startups. Based in Frankenthal, Rheinland-Pfalz, it is the investment arm of German multinational, KSB Group, a pump and valve producer. Its most recent investments were the 2019 undisclosed seed funding of industrial tech company Applied Nano Services, the 2018 undisclosed seed round in desalination innovator Salinova and the 2017 undisclosed seed investment in AddVolt, pioneer of renewable energy generation technology to replace diesel engines for cold chain transport.
Lanai Partners is an angel investors group based in Barcelona.The network of investors was formed in 2016 by a group of Spanish business angels and backed by strong partners and entrepreneurs, such as Airbnb (Europe, Middle East and Africa) managing director Jeroen Merchiers, Viko Group president Rubén Ferreiro, Housell CEO Guillermo Llibre and SocialCar founder and CEO Mar Alarcón.Lanai Partners mainly invests in early-stage funding rounds with a maximum capital of €200,000 per startup and focusing on the SaaS, marketplace and digital health sectors.
Lanai Partners is an angel investors group based in Barcelona.The network of investors was formed in 2016 by a group of Spanish business angels and backed by strong partners and entrepreneurs, such as Airbnb (Europe, Middle East and Africa) managing director Jeroen Merchiers, Viko Group president Rubén Ferreiro, Housell CEO Guillermo Llibre and SocialCar founder and CEO Mar Alarcón.Lanai Partners mainly invests in early-stage funding rounds with a maximum capital of €200,000 per startup and focusing on the SaaS, marketplace and digital health sectors.
The Rise Fund is a $2bn impact investing fund co-founded by U2 front man Bono, Bill McGlashan and Jeff Skoll. The fund has partnered with nonprofit consultancy The Bridgespan Group to develop an evidence-based model for quantifying the impact of the firm’s investments.The global impact investment vehicle is managed by TPGGrowth, part of the multibillion-dollar investment firm TPG that focuses on growth equity investments and mid-market buyouts. As of December 2019, the fund has deployed $1.4bn across its investment portfolio.
The Rise Fund is a $2bn impact investing fund co-founded by U2 front man Bono, Bill McGlashan and Jeff Skoll. The fund has partnered with nonprofit consultancy The Bridgespan Group to develop an evidence-based model for quantifying the impact of the firm’s investments.The global impact investment vehicle is managed by TPGGrowth, part of the multibillion-dollar investment firm TPG that focuses on growth equity investments and mid-market buyouts. As of December 2019, the fund has deployed $1.4bn across its investment portfolio.
Meatable: Cell-based meat startup secures $47m Series A for scalable technology
The Dutch startup offers a pioneering technology for quickly scaling cell-based meat production while eliminating the need for animal-derived growth media
Meatable joins Royal DSM to create growth media specific for cell-based meat tech
The R&D between the biotech startup and fellow Dutch nutrition conglomerate could help scale and drive the commercial viability of lab-grown meat
Cocuus: Industrial-scale solutions to design and print food
This Spanish startup is pioneering industrial-scale 3D food printing using inkjet and laser technology that prints up to 30 times faster with eye-catching food designs
Big Idea Ventures Founder Andrew D Ive: Asia will lead cell-based meat innovation
In a wide-ranging interview, the managing general partner of the US- and Singapore-based foodtech investor also expounds on his goal to extend sustainability to the rest of the food sector, combining good returns with doing good
New Food Invest: Growing an alternative protein business in Asia
With more than 4bn people, Asia presents unique opportunities and challenges to alternative protein startups. Four leading entrepreneurs shared their experiences at the recent New Food Invest conference
Because Animals: Pioneering cultured meat for pets
The biotech startup is disrupting the pet food processing industry with cell-based food to minimize environmental “pawprints” and promote animal welfare
Future Food Asia 2021: Long road ahead for the clean meat industry
Crucial basic research is still needed to ensure the safety, quality, and production efficiency of lab-grown meat. Concerted public and private sector efforts will accelerate progress
Singapore, the place to start and grow a cellular agriculture startup
A country that imports over 90% of its food supply, Singapore has turned to foodtech, including cellular agriculture, to safeguard food security, supported by proactive regulators
Cubiq Foods: Bioreactor farms producing the food of tomorrow
Growing appetite for meat alternatives expected to fuel demand for Cubiq’s low calorie, Omega 3-enriched lab-grown fats
Good Startup: Alt-protein products can be better than real meat
The investor of Eat Just, Ripple Foods and more expects its portfolio companies will exit in the next four to six years, mostly through acquisition
SWITCH Singapore: Alternative protein sure to take off in Asia, with Singapore as innovation hotbed
In an in-depth discussion, food industry experts say products made with alternative protein in hybrid forms could offer the fastest route to commercialization
Dao Foods unfazed by China tech crackdown, says alternative proteins aligned with state goals
Impact investor Dao Foods expects government support for alternative proteins to come, as it announces second batch of startups, diversifying into fermentation and cell-based proteins
Grain Meat: Focusing on whole cut plant-based meat
With its proprietary fiber weaving technique and specially-designed machinery, Wuxi-based Grain Meat aims to replicate the texture and even the grain of real meat
Biomilq: Creating cell-based mothers’ milk in a lab
With the aim of helping women struggling to breastfeed, Bill Gates-backed Biomilq is disrupting the $45bn baby formula industry developing lab-grown breast milk from mammary epithelial cells
Qorium: Lab-grown premium leather for the future of luxury
The Dutch biotech startup co-founded by cell-based meat pioneer Mark Post is targeting the luxury goods market with its “clean leather” sheets made from cultivating bovine skin cells, and plans to raise up to €100m
Sorry, we couldn’t find any matches for“cell-based meat”.
POPULAR DATABASE
